Pulmonary Vascular Diseases Program

Pulmonary hypertension is a condition where high pressure in the blood vessels within the lungs cause strain on the heart and lungs.  This can result in serious problems, including symptoms such as shortness of breath, dizziness, and difficulty with exertion.  Ultimately, it can lead to heart failure.  

The pulmonary hypertension clinic at Oregon Health & Science University is a multidisciplinary group of physicians who work to accurately diagnose and treat pulmonary hypertension. We are experts in a wide range of therapies for pulmonary hypertension, allowing us to develop a personalized treatment plan with each patient. We coordinate closely with cardiology, rheumatology, interventional radiology, and have close relationships with lung transplant centers across the west coast to ensure our patients get the absolute best care.  Additionally, we are active in clinical research, and patients have the opportunity to participate in registry trials and investigational trials for novel therapeutics that aim to further our understanding and improve outcomes in pulmonary hypertension.

Meet Our Care Team

Sherie Gause, MD

Sherie Gause, MD

Assistant Professor of Medicine

Dr. Gause was born and raised in Maryland and obtained both her undergraduate and medical degrees from the University of Maryland. She completed her internal medicine residency at the University of Pittsburgh Medical Center in 2013 and a fellowship in Pulmonary and Critical Care Medicine at the Cleveland Clinic in Ohio in 2019. During fellowship she served as the Education Chief Fellow. Her academic and clinical interests include medical education, interstitial lung disease, and sarcoidosis. During her free time Dr. Gause enjoys traveling and exploring Portland’s rich restaurant scene.

Robinson

Jeff Robinson, MD

Assistant Professor of Medicine

Dr. Robinson was born and raised in Oregon and attended Albert Einstein College of Medicine.  Following his internal medicine training at the University of California – Davis, he completed his pulmonary and critical care fellowship at University of Colorado, where he joined faculty as assistant professor.  His academic interests include advancing the care of pulmonary hypertension through clinical trials.  Clinically, his main interests are the care of patients with pulmonary hypertension and autoimmune-related lung disease.  Additionally, Dr. Robinson attends in both the medical and cardiac intensive care units.

HS-BLANK

Raju Reddy, MD

Dr. Reddy completed his Internal Medicine residency at University of Texas, Austin and Pulmonary and Critical Care fellowship at University of Southern California, Los Angeles. He also served as an Assistant Professor at University of Florida, Gainesville before moving to OHSU. His clinical interests are pulmonary hypertension and acute respiratory distress syndrome. Raju enjoys working with fellows, residents, and medical students. In his free time, he enjoys hiking, traveling and spending time with his dogs.

Nalini Colaco

Nalini Colaco, MD, PhD

Assistant Professor of Medicine, Division of Cardiovascular Medicine

Dr. Colaco is a cardiologist who specializes in the care of patients with advanced heart failure, including evaluation for mechanical heart pumps and heart transplantation. She cares for patients in both the outpatient and inpatient setting, and provides compassionate, thoughtful, communicative and individualized care to patients and their families as they navigate through the disease course. She feels privileged to be able to build lifelong relationships with patients and provide care in both sickness and in health. A native of the west coast, Dr. Colaco enjoys everything that the pacific northwest has to offer including hiking, biking and delicious food and drink.

  • Kellee Larson, RN, BSN

PH Clinical Coordinator

OHSU Pulmonary Hypertension Clinical Trials

  • A-DUE: A randomized controlled trial looking at combination oral therapy with Macitentan/Tadalafil.
  • UNISUS: A randomized controlled trial investigating a different dose of the medication Macitentan.
  • MaciTeph: A study examining the effects of Macitentan in treatment of chronic thromboembolic pulmonary hypertension.
  • ADVANCE:  A randomized and double blinded study examining the role of a novel oral medication in treating pulmonary arterial hypertension.
  • Liquidia (LTI-301/302): A study examining an inhaled medication in treatment of pulmonary arterial hypertension.

Contact Information

Our clinic is located at:
OHSU Physicians Pavilion Suite #320
3270 SW Pavilion Loop
Portland, OR 97239

Parking: Parking garage B is connected to the Physicians Pavilion and will bring you up to the third floor of the building. Patients can also access free valet parking on the fourth level of the parking garage.

New Patients, please call 503-494-9400  to schedule an appointment, then fax documents (including any prior test results, echocardiograms, lung scans, or catheterizations) to 503-346-8175.

Established patients, please call 503-494-1620 and fax documents to 503-494-6465.